Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
GGP13082
Telethon - Italy
R01 HL120728
NHLBI NIH HHS - United States
U54 HL112311
NHLBI NIH HHS - United States
P30 CA046934
NCI NIH HHS - United States
K01 GM103806
NIGMS NIH HHS - United States
MOP-81208
Canadian Institutes of Health Research - Canada
UL1 TR001082
NCATS NIH HHS - United States
GM103806
NIGMS NIH HHS - United States
MOP-259952
Canadian Institutes of Health Research - Canada
HL112311
NHLBI NIH HHS - United States
PubMed
25807284
PubMed Central
PMC4631613
DOI
10.1038/ng.3253
Knihovny.cz E-zdroje
- MeSH
- abnormální erytrocyty MeSH
- akutní lymfatická leukemie genetika MeSH
- dospělí MeSH
- exom MeSH
- genetická predispozice k nemoci MeSH
- genetické asociační studie MeSH
- HEK293 buňky MeSH
- krevní nemoci genetika MeSH
- lidé MeSH
- missense mutace MeSH
- mutační analýza DNA MeSH
- předškolní dítě MeSH
- protein ETS, translokační varianta 6 MeSH
- protoonkogenní proteiny c-ets genetika MeSH
- represorové proteiny genetika MeSH
- rodokmen MeSH
- trombocytopenie genetika MeSH
- zárodečné mutace MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Názvy látek
- protoonkogenní proteiny c-ets MeSH
- represorové proteiny MeSH
Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia. We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.
Children's Hospital of Michigan Wayne State University Detroit MI USA
Department of Biochemistry and Molecular Genetics University of Colorado AMC Aurora Colorado USA
Department of Biochemistry University of Toronto Toronto Ontario Canada
Department of Internal Medicine Haematology Oncology University Hospital Brno
Department of Internal Medicine University of Utah Salt Lake City Utah USA
Department of Medical Sciences University of Trieste Trieste Italy
Department of Pathology University of Colorado AMC Aurora Colorado USA
Department of Pediatrics University of Colorado Anschutz Medical Campus Aurora Colorado CO USA
Departments of Medicine University of Colorado AMC Aurora Colorado USA
Human Medical Genetics and Genomics Program University of Colorado AMC Aurora Colorado USA
Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy
Molecular Medicine Program University of Utah Salt Lake City Utah USA
Program in Cell Biology Research Institute The Hospital for Sick Children Toronto Ontario Canada
Zobrazit více v PubMed
Song WJ, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166–75. PubMed
Nichols KE, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266–70. PubMed PMC
Kar A, Gutierrez-Hartmann A. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit Rev Biochem Mol Biol. 2013;48:522–43. PubMed PMC
Romana SP, et al. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21) Leukemia. 1996;10:167–70. PubMed
Patel N, et al. Expression profile of wild-type ETV6 in childhood acute leukaemia. Br J Haematol. 2003;122:94–8. PubMed
Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene. 2005;24:4129–37. PubMed
Bejar R, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011;364:2496–506. PubMed PMC
Van Vlierberghe P, et al. ETV6 mutations in early immature human T cell leukemias. J Exp Med. 2011;208:2571–9. PubMed PMC
Zhang MY, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47:180–5. PubMed PMC
Rasighaemi P, Onnebo SM, Liongue C, Ward AC. ETV6 (TEL1) regulates embryonic hematopoiesis in zebrafish. Haematologica. 2014 PubMed PMC
Wang LC, et al. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 1997;16:4374–83. PubMed PMC
Wang LC, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 1998;12:2392–402. PubMed PMC
Hock H, et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 2004;18:2336–41. PubMed PMC
Pereira CF, et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell. 2013;13:205–18. PubMed PMC
Orkin SH, et al. Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature. 1982;300:768–9. PubMed
Green SM, Coyne HJ, 3rd, McIntosh LP, Graves BJ. DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association. J Biol Chem. 2010;285:18496–504. PubMed PMC
Kwiatkowski BA, et al. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem. 1998;273:17525–30. PubMed
Raslova H, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest. 2004;114:77–84. PubMed PMC
Million RP, Harakawa N, Roumiantsev S, Varticovski L, Van Etten RA. A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase. Mol Cell Biol. 2004;24:4685–95. PubMed PMC
Roukens MG, Alloul-Ramdhani M, Moghadasi S, Op den Brouw M, Baker DA. Downregulation of vertebrate Tel (ETV6) and Drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitination. Mol Cell Biol. 2008;28:4394–406. PubMed PMC
Lopez RG, et al. TEL is a sequence-specific transcriptional repressor. J Biol Chem. 1999;274:30132–8. PubMed
Fenrick R, et al. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol. 2000;20:5828–39. PubMed PMC
Machlus KR, Italiano JE., Jr The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol. 2013;201:785–96. PubMed PMC
Mullighan CG, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758–64. PubMed
Strehl S, Konig M, Dworzak MN, Kalwak K, Haas OA. PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13) Leukemia. 2003;17:1121–3. PubMed
Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics. 2010;26:873–881. PubMed PMC
McKenna A, et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research. 2010;20:1297–1303. PubMed PMC
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research. 2010;38:e164. PubMed PMC
Liu X, Jian X, Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894–899. PubMed PMC
Rowley JW, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118:e101–11. PubMed PMC
Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–50. PubMed PMC
Kim D, Salzberg S. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biology. 2011;12:R72. PubMed PMC
Ge H, et al. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics. 2011;27:1922–1928. PubMed
Wilcox DA, et al. Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII. J Thromb Haemost. 2003;1:2477–89. PubMed
Kahr WH, et al. Abnormal megakaryocyte development and platelet function in Nbeal2(−/−) mice. Blood. 2013;122:3349–58. PubMed PMC
Urban D, et al. The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet alpha-granule biogenesis. Blood. 2012;120:5032–40. PubMed PMC